Mary Kay Fenton
2013 - Achillion Pharmaceuticals
In 2013, Mary Kay Fenton earned a total compensation of $989.6K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $74,256 |
|---|---|
| Option Awards | $580,968 |
| Salary | $326,400 |
| Other | $7,992 |
| Total | $989,616 |
Fenton received $581K in option awards, accounting for 59% of the total pay in 2013.
Fenton also received $74.3K in non-equity incentive plan, $326.4K in salary and $8K in other compensation.
Rankings
In 2013, Mary Kay Fenton's compensation ranked 6,668th out of 12,286 executives tracked by ExecPay. In other words, Fenton earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,668 out of 12,286 | 46th |
Division Manufacturing | 2,351 out of 4,612 | 49th |
Major group Chemicals And Allied Products | 703 out of 1,466 | 52nd |
Industry group Drugs | 514 out of 1,160 | 56th |
Industry Pharmaceutical Preparations | 406 out of 890 | 54th |
Source: SEC filing on April 15, 2016.
Fenton's colleagues
We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2013.
2013
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2013
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2013
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2013
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2013
Michael Kishbauch
Achillion Pharmaceuticals